vimarsana.com

Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human Subjects

Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human Subjects

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Australia ,New Zealand ,Russia ,Ukraine ,Daiichi Sankyo ,Contactkogs Communicationedna Kaplan ,Andreas Muehler ,Daniel Vitt ,Exchange Commission ,Daiichi Sankyo Co Ltd ,Us Ir Contactrx Communications Grouppaula Schwartz ,Prnewswire Immunic Inc ,Nasdaq ,Immunic Inc ,Unblinded Data Revealed ,Favorable Safety ,Pharmacokinetic Profile ,Day Multiple Dosing ,Investigated Doses Expected ,Exceed Required Therapeutic Dosing ,Third Portion ,Celiac Disease Ongoing ,Held Today ,Investigational Medicinal Product ,Chief Medical Officer ,Chief Executive Officer ,Eastern Time ,Private Securities Litigation Reform Act ,Annual Report ,Inc Jessica Breuhead ,Investor Relations ,

vimarsana.com © 2020. All Rights Reserved.